10 New Drugs for Primary Care: Q3 2019
October 10, 2019
The third quarter saw many novel drugs receiving FDA-approval for a variety of conditions often seen in primary care.
Recent Content
How Can Motivational Interviewing Help Improve Medication Adherence in CF?
October 9, 2019
Rates of adherence to cystic fibrosis treatment plans have been reported as low as 36%. The motivational interviewing approach could help, according to MI trainer Ellen R. Glovsky, PhD, RD, LDN.
Motivational Interviewing: A Brief Introduction
October 9, 2019
Motivational interviewing uses the common human problem of ambivalence about change to help clients shape their own solutions.
Lipid Guidelines, Compared: ACC/AHA and ESC/EAS
October 9, 2019
The European and American guidelines on dyslipidemia management overlap but also diverge in critical ways. A Johns Hopkins cardiologist highlights similarities and differences.
"Brain Pacemaker" Shows Promise for Treatment-Resistant Depression
October 8, 2019
A new study suggests that deep brain stimulation may be a safe and effective treatment option for patients with treatment-resistant depression.
A Mobile App Helps Youth, Physicians Manage Migraine
October 8, 2019
Children, tweens, and adolescents with migraine can use Migraine Trainer to log and share details that will help physicians individualize care in this vulnerable population.
Glycemic Control Improves with Motivational Texts
October 7, 2019
For people with type 2 diabetes, receiving motivational messages via mobile text was associated with reduced A1c vs patients who received usual care.
FDA Announced Approval of Second HIV-Prevention Drug
October 4, 2019
The FDA announced October 3 approval of Descovy®, making it the second drug to receive indication for HIV pre-exposure prophylaxis.
When Confronted with Atypical Headache, You May Have to SNOOP
October 4, 2019
Throbbing occipital headache x2 wks; abrupt onset, no history. Reason for alarm? Neurologist Peter McAllister, MD, suggests you SNOOP first.
Sexual Health Fables, Fallacies, and Risk Mitigation: 6 Studies
October 4, 2019
Vaccines against herpes and chlamydia show promise but sexual health awareness in the US leaves a lot to be desired. The research explains.
